Denosumab Subcutaneous and Oxcarbazepine Extended-Release Tablets
Determining the interaction of Denosumab Subcutaneous and Oxcarbazepine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denosumab
Brand name: Prolia, Xgeva
Synonyms: Denosumab
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denosumab Subcutaneous-Oxcarbazepine Oral Suspension
- Denosumab Subcutaneous-Oxcarbazepine Suspension
- Denosumab Subcutaneous-Oxcarbazepine Tablets
- Denosumab Subcutaneous-Oxecta
- Denosumab Subcutaneous-Oxilan
- Denosumab Subcutaneous-Oxipor VHC
- Oxcarbazepine Extended-Release Tablets-Denovo
- Oxcarbazepine Extended-Release Tablets-Dent-O-Kain/20
- Oxcarbazepine Extended-Release Tablets-Denti-Care Denti-Freeze Topical Anesthetic
- Oxcarbazepine Extended-Release Tablets-DentiPatch
- Oxcarbazepine Extended-Release Tablets-Deoxycholic acid
- Oxcarbazepine Extended-Release Tablets-Deoxycholic acid Subcutaneous